Literature DB >> 23716717

Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinases.

Sen Chen1, Xinnong Jiang1, Christina A Gewinner2, John M Asara2, Nicholas I Simon1, Changmeng Cai1, Lewis C Cantley2,3, Steven P Balk1.   

Abstract

The nonreceptor tyrosine kinase BMX (bone marrow tyrosine kinase gene on chromosome X) is abundant in various cell types and activated downstream of phosphatidylinositol-3 kinase (PI3K) and the kinase Src, but its substrates are unknown. Positional scanning peptide library screening revealed a marked preference for a priming phosphorylated tyrosine (pY) in the -1 position, indicating that BMX substrates may include multiple tyrosine kinases that are fully activated by pYpY sites in the kinase domain. BMX phosphorylated focal adhesion kinase (FAK) at Tyr⁵⁷⁷ subsequent to its Src-mediated phosphorylation at Tyr⁵⁷⁶. Loss of BMX by RNA interference or by genetic deletion in mouse embryonic fibroblasts (MEFs) markedly impaired FAK activity. Phosphorylation of the insulin receptor in the kinase domain at Tyr¹¹⁸⁹ and Tyr¹¹⁹⁰, as well as Tyr¹¹⁸⁵, and downstream phosphorylation of the kinase AKT at Thr³⁰⁸ were similarly impaired by BMX deficiency. However, insulin-induced phosphorylation of AKT at Ser⁴⁷³ was not impaired in Bmx knockout MEFs or liver tissue from Bmx knockout mice, which also showed increased insulin-stimulated glucose uptake, possibly because of decreased abundance of the phosphatase PHLPP (PH domain leucine-rich repeat protein phosphatase). Thus, by identifying the pYpY motif as a substrate for BMX, our findings suggest that BMX functions as a central regulator among multiple signaling pathways mediated by tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23716717      PMCID: PMC3735445          DOI: 10.1126/scisignal.2003936

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  58 in total

1.  Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog.

Authors:  S R Hubbard
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

2.  Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1.

Authors:  Changmeng Cai; Housheng Hansen He; Sen Chen; Ilsa Coleman; Hongyun Wang; Zi Fang; Shaoyong Chen; Peter S Nelson; X Shirley Liu; Myles Brown; Steven P Balk
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

3.  Determining in vivo phosphorylation sites using mass spectrometry.

Authors:  Susanne B Breitkopf; John M Asara
Journal:  Curr Protoc Mol Biol       Date:  2012-04

4.  Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3.

Authors:  Olga A Guryanova; Qiulian Wu; Lin Cheng; Justin D Lathia; Zhi Huang; Jinbo Yang; Jennifer MacSwords; Christine E Eyler; Roger E McLendon; John M Heddleston; Weinian Shou; Dolores Hambardzumyan; Jeongwu Lee; Anita B Hjelmeland; Andrew E Sloan; Markus Bredel; George R Stark; Jeremy N Rich; Shideng Bao
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

5.  The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta.

Authors:  P Saharinen; N Ekman; K Sarvas; P Parker; K Alitalo; O Silvennoinen
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

6.  The holo-apoptosome: activation of procaspase-9 and interactions with caspase-3.

Authors:  Shujun Yuan; Xinchao Yu; John M Asara; John E Heuser; Steven J Ludtke; Christopher W Akey
Journal:  Structure       Date:  2011-08-10       Impact factor: 5.006

7.  Regulatory intramolecular association in a tyrosine kinase of the Tec family.

Authors:  A H Andreotti; S C Bunnell; S Feng; L J Berg; S L Schreiber
Journal:  Nature       Date:  1997-01-02       Impact factor: 49.962

8.  Using tandem mass spectrometry in targeted mode to identify activators of class IA PI3K in cancer.

Authors:  Xuemei Yang; Alexa B Turke; Jie Qi; Youngchul Song; Brent N Rexer; Todd W Miller; Pasi A Jänne; Carlos L Arteaga; Lewis C Cantley; Jeffrey A Engelman; John M Asara
Journal:  Cancer Res       Date:  2011-07-20       Impact factor: 12.701

9.  Regulation of Btk by Src family tyrosine kinases.

Authors:  D E Afar; H Park; B W Howell; D J Rawlings; J Cooper; O N Witte
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

10.  The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner.

Authors:  Marie Gottar-Guillier; Francis Dodeller; Dieter Huesken; Vadim Iourgenko; Craig Mickanin; Mark Labow; Samuel Gaveriaux; Bernd Kinzel; Matthias Mueller; Kari Alitalo; Amanda Littlewood-Evans; Bruno Cenni
Journal:  J Immunol       Date:  2011-04-06       Impact factor: 5.422

View more
  14 in total

1.  Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer.

Authors:  Ziyang Yu; Sen Chen; Adam G Sowalsky; Olga S Voznesensky; Elahe A Mostaghel; Peter S Nelson; Changmeng Cai; Steven P Balk
Journal:  Clin Cancer Res       Date:  2014-01-21       Impact factor: 12.531

Review 2.  AR-dependent phosphorylation and phospho-proteome targets in prostate cancer.

Authors:  Varadha Balaji Venkadakrishnan; Salma Ben-Salem; Hannelore V Heemers
Journal:  Endocr Relat Cancer       Date:  2020-06       Impact factor: 5.678

3.  Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia.

Authors:  Jolieke G van Oosterwijk; Daelynn R Buelow; Christina D Drenberg; Aksana Vasilyeva; Lie Li; Lei Shi; Yong-Dong Wang; David Finkelstein; Sheila A Shurtleff; Laura J Janke; Stanley Pounds; Jeffrey E Rubnitz; Hiroto Inaba; Navjotsingh Pabla; Sharyn D Baker
Journal:  J Clin Invest       Date:  2017-12-11       Impact factor: 14.808

4.  Urotensin-II receptor stimulation of cardiac L-type Ca2+ channels requires the βγ subunits of Gi/o-protein and phosphatidylinositol 3-kinase-dependent protein kinase C β1 isoform.

Authors:  Yuan Zhang; Jiaoqian Ying; Dongsheng Jiang; Zhigang Chang; Hua Li; Guoqiang Zhang; Shan Gong; Xinghong Jiang; Jin Tao
Journal:  J Biol Chem       Date:  2015-02-12       Impact factor: 5.157

Review 5.  Homing in: Mechanisms of Substrate Targeting by Protein Kinases.

Authors:  Chad J Miller; Benjamin E Turk
Journal:  Trends Biochem Sci       Date:  2018-03-12       Impact factor: 13.807

6.  Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells.

Authors:  Nicole Grabinski; Florian Ewald
Journal:  Invest New Drugs       Date:  2014-08-01       Impact factor: 3.850

7.  BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer.

Authors:  Sen Chen; Changmeng Cai; Adam G Sowalsky; Huihui Ye; Fen Ma; Xin Yuan; Nicholas I Simon; Nathanael S Gray; Steven P Balk
Journal:  Cancer Res       Date:  2018-07-16       Impact factor: 12.701

8.  Substrate priming enhances phosphorylation by the budding yeast kinases Kin1 and Kin2.

Authors:  Grace R Jeschke; Hua Jane Lou; Keith Weise; Charlotte I Hammond; Mallory Demonch; Patrick Brennwald; Benjamin E Turk
Journal:  J Biol Chem       Date:  2018-10-10       Impact factor: 5.157

9.  EGF-receptor specificity for phosphotyrosine-primed substrates provides signal integration with Src.

Authors:  Michael J Begley; Cai-hong Yun; Christina A Gewinner; John M Asara; Jared L Johnson; Anthony J Coyle; Michael J Eck; Irina Apostolou; Lewis C Cantley
Journal:  Nat Struct Mol Biol       Date:  2015-11-09       Impact factor: 15.369

10.  Hypoxia Reporter Element Assay.

Authors:  Daelynn R Buelow; Sharyn D Baker
Journal:  Bio Protoc       Date:  2018-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.